Partners
Collaborate with Us
At Quotient Therapeutics, we believe the promise of somatic genomics extends far beyond our core areas of focus. We seek to collaborate with partners who share our vision of leveraging these unprecedented insights into disease biology to drive the discovery of potentially breakthrough medicines. Together, we can broaden the impact of somatic genomics and bring its transformative potential to the patients who need it most.
Current Collaborators
-
Pfizer
In 2024, we announced a collaboration with Pfizer and Flagship’s Pioneering Medicines to discover new targets for cardiovascular disease. Read More.
Team
Recognized Leaders
Technology
A new status Quo in R&D